Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Information about the 2019 Novel Coronavirus
Gabapentin enacarbil in subjects with moderate to severe primary restless legs syndrome with and without severe sleep disturbance: an integrated analysis of subjective and novel sleep endpoints from two studies JOURNAL OF PARKINSONISM AND RESTLESS LEGS SYNDROME Bogan, R. K., Ellenbogen, A., Becker, P. M., Kushida, C., Ball, E., Ondo, W. G., Caivano, C. K., Kavanagh, S. 2013; 3: 31–40
View details for DOI 10.2147/JPRLS.S40804
View details for Web of Science ID 000215701900004